<HashMap><database>ENA</database><file_versions><headers><Content-Type>application/xml</Content-Type></headers><body><files><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/040/SRR28160640/SRR28160640_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/041/SRR28160641/SRR28160641_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/044/SRR28160644/SRR28160644_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/039/SRR28160639/SRR28160639_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/043/SRR28160643/SRR28160643_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/042/SRR28160642/SRR28160642_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/040/SRR28160640/SRR28160640_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/043/SRR28160643/SRR28160643_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/044/SRR28160644/SRR28160644_1.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/039/SRR28160639/SRR28160639_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/042/SRR28160642/SRR28160642_2.fastq.gz</Fastqsanger.gz><Fastqsanger.gz>ftp://ftp.sra.ebi.ac.uk/vol1/fastq/SRR281/041/SRR28160641/SRR28160641_1.fastq.gz</Fastqsanger.gz></files><type>primary</type></body><statusCode>OK</statusCode><statusCodeValue>200</statusCodeValue></file_versions><scores/><additional><omics_type>Genomics</omics_type><center_name>Zhuzhou Central Hospital, Xiangya Hospital Zhuzhou Central South University, Central South Universit</center_name><full_dataset_link>https://www.ebi.ac.uk/ena/browser/view/PRJNA1082038</full_dataset_link><tag>xref:EuropePMC:PMC11911279</tag><long_description>Research has shown that ESM1 is closely related to the occurrence and development of ovarian cancer (OC), and can be regarded as a new biomarker and therapeutic target for OC patients. However, the specific carcinogenic mechanism of ESM1 in OC still needs further clarification. In this study, differential genes regulated by Endothelial cell-specific molecule 1 (ESM1) were screened by mRNA sequencing. mRNA sequencing revealed that ESM1 regulation of lipid metabolism in OC was related to Beclin 1 (BECN1).</long_description><repository>ENA</repository><description_synonyms>Ovary Cancer, Cancer of Ovary, E130207K11, EGR[a], ovarian neoplasm, GT197, Neoplasms, Gdnfif, AV004503, Ovary, AW215868, VPS30, Ovary Cancers, Feedbacks., RGD1309496, 0610042H23Rik, OFOXD1, malignant tumour of ovary, ovarian cancer, mGIF, epithelial, Ovarian, Metabolism, malignant Ovarian tumor, AW050020, Lipid, ESM-1, Neoplasm, EGR-alpha, 5430417M23Rik, OFOXD, Ovary Neoplasm, Cancer of the Ovary, lipid metabolism, TIEG-1, Tieg1, Ofoxd, Ovarian Cancer, ABH5, Tieg, Abh5, ovarian epithelial cancer, OC, Ovary Neoplasms, Cancers, epithiospecifier modifier 1, ATG6, primary ovarian cancer, Atg6, ovary neoplasm, AI115143, 4921513J16Rik, beclin1, endocan, Egral, Ovarian Neoplasm, tumor of the Ovary, TIEG, EGRA, Ovarian Cancers, TIEG1, Cancer</description_synonyms></additional><is_claimable>false</is_claimable><name></name><description>ESM1-mediated lipid metabolism reprogramming in ovarian cancer: ALKBH5/ESM1/KLF10/BECN1 positive feedback</description><dates><last_updated>2024-03-30</last_updated><first_public>2024-03-30</first_public></dates><accession>PRJNA1082038</accession><cross_references/></HashMap>